{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:41:48Z","timestamp":1753890108811,"version":"3.41.2"},"reference-count":17,"publisher":"Siapec Servizi Srl","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-975","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:41:34Z","timestamp":1749195694000},"page":"156-161","source":"Crossref","is-referenced-by-count":0,"title":["Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation"],"prefix":"10.32074","volume":"117","author":[{"given":"Elisabetta","family":"Merenda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Scalzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Licci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Bizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2025,5]]},"reference":[{"key":"10.32074\/1591-951X-975_ref1","doi-asserted-by":"crossref","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(1):129-148. https:\/\/doi.org\/10.1002\/ajh.26352","DOI":"10.1002\/ajh.26352"},{"key":"10.32074\/1591-951X-975_ref2","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200-1228. https:\/\/doi.org\/10.1182\/blood.2022015850","DOI":"10.1182\/blood.2022015850"},{"key":"10.32074\/1591-951X-975_ref3","doi-asserted-by":"crossref","unstructured":"Kim AS, Pozdnyakova O. SOHO State of the Art Updates and Next Questions | Myeloid\/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls. Clin Lymphoma Myeloma Leuk. 2022;22(9):643-651. https:\/\/doi.org\/10.1016\/j.clml.2022.03.008","DOI":"10.1016\/j.clml.2022.03.008"},{"key":"10.32074\/1591-951X-975_ref4","doi-asserted-by":"crossref","unstructured":"Zanelli M, Smith M, Zizzo M, et al. A tricky and rare cause of pulmonary eosinophilia: myeloid\/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA. BMC Pulm Med. 2019;19(1):216. Published 2019 Nov 19. https:\/\/doi.org\/10.1186\/s12890-019-0967-7","DOI":"10.1186\/s12890-019-0967-7"},{"key":"10.32074\/1591-951X-975_ref5","doi-asserted-by":"crossref","unstructured":"Saft L, Kvasnicka HM, Boudova L, Gianelli U, Lazzi S, Rozman M. Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases. Histopathology. 2023;83(6):829-849. https:\/\/doi.org\/10.1111\/his.15021","DOI":"10.1111\/his.15021"},{"key":"10.32074\/1591-951X-975_ref6","doi-asserted-by":"crossref","unstructured":"Metzgeroth G, Schwaab J, Naumann N, et al. Treatment-free remission in FIP1L1-PDGFRA-positive myeloid\/lymphoid neoplasms with eosinophilia after imatinib discontinuation. Blood Adv. 2020; 4(3):440-443https:\/\/doi.org\/10.1182\/bloodadvances.2019001111","DOI":"10.1182\/bloodadvances.2019001111"},{"key":"10.32074\/1591-951X-975_ref7","doi-asserted-by":"crossref","unstructured":"Pozdnyakova O, Orazi A, Kelemen K, et al. Myeloid\/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Am J Clin Pathol. 2021;155(2):160-178. https:\/\/doi.org\/10.1093\/ajcp\/aqaa208","DOI":"10.1093\/ajcp\/aqaa208"},{"key":"10.32074\/1591-951X-975_ref8","doi-asserted-by":"crossref","unstructured":"Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994;77(2):307-316. https:\/\/doi.org\/10.1016\/0092-8674(94)90322-0","DOI":"10.1016\/0092-8674(94)90322-0"},{"key":"10.32074\/1591-951X-975_ref9","unstructured":"Bain BJ, Gilliland DG, Horny H-P, Vardiman JW. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB and FGFR1. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and Vardiman JW (eds) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue, 4th edn. 2008 IARC Press, Lyon, pp. 68-73."},{"key":"10.32074\/1591-951X-975_ref10","unstructured":"Schaller JL, Burkland GA. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. MedGenMed. 2001;3(5):9. Published 2001 Sep 7."},{"key":"10.32074\/1591-951X-975_ref11","doi-asserted-by":"crossref","unstructured":"Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 2002;347(7):481-487. https:\/\/doi.org\/10.1056\/NEJMoa020150","DOI":"10.1056\/NEJMoa020150"},{"key":"10.32074\/1591-951X-975_ref12","doi-asserted-by":"crossref","unstructured":"Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348(13):1201-1214. https:\/\/doi.org\/10.1056\/NEJMoa025217","DOI":"10.1056\/NEJMoa025217"},{"key":"10.32074\/1591-951X-975_ref13","doi-asserted-by":"crossref","unstructured":"James W. Vardiman, J\u00fcergen Thiele, Daniel A. Arber, Richard D. Brunning, Michael J. Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M. Le Beau, Eva Hellstr\u00f6m-Lindberg, Ayalew Tefferi, Clara D. Bloomfield; The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114 (5): 937\u2013951. https:\/\/doi.org\/10.1182\/blood-2009-03-209262","DOI":"10.1182\/blood-2009-03-209262"},{"key":"10.32074\/1591-951X-975_ref14","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405. Blood. 2016;128(3):462-463. https:\/\/doi.org\/10.1182\/blood-2016-06-721662","DOI":"10.1182\/blood-2016-06-721662"},{"key":"10.32074\/1591-951X-975_ref15","doi-asserted-by":"crossref","unstructured":"Wang SA, Orazi A, Gotlib J, Reiter A, Tzankov A, Hasserjian RP, Arber DA, Tefferi A. The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol. 2023 Aug;98(8):1286-1306. https:\/\/doi.org\/10.1002\/ajh.26966.","DOI":"10.1002\/ajh.26966"},{"key":"10.32074\/1591-951X-975_ref16","doi-asserted-by":"crossref","unstructured":"Reiter A, Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129(6):704-714. https:\/\/doi.org\/10.1182\/blood-2016-10-695973","DOI":"10.1182\/blood-2016-10-695973"},{"key":"10.32074\/1591-951X-975_ref17","doi-asserted-by":"crossref","unstructured":"Pardanani A, Brockman SR, Paternoster SF, et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood. 2004;104(10):3038-3045. https:\/\/doi.org\/10.1182\/blood-2004-03-0787","DOI":"10.1182\/blood-2004-03-0787"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:43:34Z","timestamp":1749195814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-975","relation":{},"ISSN":["1591-951X"],"issn-type":[{"type":"electronic","value":"1591-951X"}],"subject":[],"published":{"date-parts":[[2025,5]]},"article-number":"11"}}